Cytoplasmic PELP1 and ERRgamma protect human mammary epithelial cells from Tam-induced cell death

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Girard, Brian J ^a   Anderson, Tarah M Regan ^a   Welch, Siya Lem ^b   Nicely, Julie ^b   Seewaldt, Victoria L ^b   Ostrander, Julie H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOPLASM PROTEIN; ESTROGEN RECEPTOR; PROTEIN ERR GAMMA; PROTEIN PELP1; STROMELYSIN; TAMOXIFEN; UNCLASSIFIED DRUG; COREPRESSOR PROTEIN; ESRRG PROTEIN, HUMAN; PELP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; BREAST EPITHELIUM CELL; CANCER INHIBITION; CELL IMMORTALIZATION; CELL PROTECTION; CELL SURVIVAL; DRUG RECEPTOR BINDING; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION; BREAST TUMOR; CARCINOGENESIS; CYTOLOGY; CYTOPLASM; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MAMMARY GLAND; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; RISK; TUMOR CELL LINE;

AUTOPHAGY; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CO-REPRESSOR PROTEINS; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MAMMARY GLANDS, HUMAN; PROTEIN TRANSPORT; RECEPTORS, ESTROGEN; RISK; TAMOXIFEN; TRANSCRIPTION FACTORS;

EID: 84925624858     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121206     Document Type: Article

References (53)

1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, et al. (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388. PMID: 9747868
2. Tan CK, Chow PK, Findlay M, Wong C, Machin D (2000) Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift. J Gastroenterol Hepatol 15: 725-729. PMID: 10937676
3. Benson JR, Wakefield LM, Baum M, Colletta AA (1996) Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen. Br J Cancer 74: 352-358. PMID: 8695348
4. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB (1985) Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465. PMID: 3157445
5. Lopes MC, Vale MG, Carvalho AP (1990) Ca2(+)-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res 50: 2753-2758. PMID: 2139360
6. Thomas P, Pang Y, Filardo EJ, Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632. PMID: 15539556
7. Tremblay GB, Bergeron D, Giguere V (2001) 4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors beta and gamma. Endocrinology 142: 4572-4575. PMID: 11564725
8. Friedman ZY (1998) Recent advances in understanding the molecular mechanisms of tamoxifen action. Cancer Invest 16: 391-396. PMID: 9679530
9. Greschik H, Wurtz JM, Sanglier S, Bourguet W, van Dorsselaer A, et al. (2002) Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol Cell 9: 303-313. PMID: 11864604
10. Lu X, Peng L, Lv M, Ding K (2012) Recent advance in the design of small molecular modulators of estrogen- related receptors. Curr Pharm Des 18: 3421-3431. PMID: 22632982
11. Deblois G, Giguere V (2011) Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochim Biophys Acta 1812: 1032-1040. doi: 10.1016/j.bbadis.2010.12.009 PMID: 21172432
12. Ariazi EA, Clark GM, Mertz JE (2002) Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 62: 6510-6518. PMID: 12438245
13. Riggins RB, Lan JP, Zhu Y, Klimach U, Zwart A, et al. (2008) ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res 68: 8908-8917. doi: 10.1158/0008-5472.CAN-08-2669 PMID: 18974135
14. Heckler MM, Thakor H, Schafer CC, Riggins RB (2014) ERK/MAPK regulates ERRgamma expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer. FEBS J 281: 2431-2442. doi: 10.1111/febs.12797 PMID: 24684682
15. Vadlamudi RK, Manavathi B, Balasenthil S, Nair SS, Yang Z, et al. (2005) Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 65: 7724-7732. PMID: 16140940
16. Vadlamudi RK, Wang RA, Mazumdar A, Kim Y, Shin J, et al. (2001) Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem 276: 38272-38279. PMID: 11481323
17. Vadlamudi RK, Manavathi B, Balasenthil S, Nair SS, Yang Z, et al. (2005) Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer research 65: 7724-7732. PMID: 16140940
18. Kumar R, Zhang H, Holm C, Vadlamudi RK, Landberg G, et al. (2009) Extranuclear coactivator signaling confers insensitivity to tamoxifen. Clinical cancer research: an official journal of the American Association for Cancer Research 15: 4123-4130. doi: 10.1158/1078-0432.CCR-08-2347 PMID: 19470742
19. Ostrander JH, McMahon CM, Lem S, Millon SR, Brown JQ, et al. (2010) Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Res 70: 4759-4766. doi: 10. 1158/0008-5472.CAN-09-2572 PMID: 20460512
20. Garbe JC, Vrba L, Sputova K, Fuchs L, Novak P, et al. (2014) Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. Cell Cycle 13: 3423-3435. doi: 10.4161/15384101.2014.954456 PMID: 25485586
21. Debnath J, Muthuswamy SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268. PMID: 12798140
22. Garbe JC, Bhattacharya S, Merchant B, Bassett E, Swisshelm K, et al. (2009) Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res 69: 7557-7568. doi: 10.1158/0008-5472.CAN-09-0270 PMID: 19773443
23. Krishan A (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188-193. PMID: 49354
24. Twentyman PR, Luscombe M (1987) A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56: 279-285. PMID: 3663476
25. Baker JC Jr., Ostrander JH, Lem S, Broadwater G, Bean GR, et al. (2008) ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention. Cancer Epidemiol Biomarkers Prev 17: 1884-1890. doi: 10.1158/1055-9965.EPI-07-2696 PMID: 18708376
26. Dietze EC, Caldwell LE, Grupin SL, Mancini M, Seewaldt VL (2001) Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization. J Biol Chem 276: 5384-5394. PMID: 11094056
27. Dietze EC, Troch MM, Bean GR, Heffner JB, Bowie ML, et al. (2004) Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity. Oncogene 23: 3851-3862. PMID: 14990993
28. Seewaldt VL, Mrozek K, Dietze EC, Parker M, Caldwell LE (2001) Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis. Cancer Res 61: 616-624. PMID: 11212259
29. Charlier C, Chariot A, Antoine N, Merville MP, Gielen J, et al. (1995) Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem Pharmacol 49: 351-358. PMID: 7857322
30. Grenman SE, Van Dyke DL, Worsham MJ, England B, McClatchey KD, et al. (1990) Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer 45: 920-927. PMID: 2335395
31. Grenman SE, Worsham MJ, Van Dyke DL, England B, McClatchey KD, et al. (1990) Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line. Gynecol Oncol 37: 188-199. PMID: 2344964
32. Cho KS, Yoon YH, Choi JA, Lee SJ, Koh JY (2012) Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells. Invest Ophthalmol Vis Sci 53: 5344-5353. doi: 10.1167/iovs.12-9827 PMID: 22786900
33. Robertson DW, Katzenellenbogen JA, Long DJ, Rorke EA, Katzenellenbogen BS (1982) Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen. J Steroid Biochem 16: 1-13. PMID: 7062732
34. MacGregor JI, Jordan VC (1998) Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50: 151-196. PMID: 9647865
35. Frasor J, Chang EC, Komm B, Lin CY, Vega VB, et al. (2006) Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res 66: 7334-7340. PMID: 16849584
36. Mandlekar S, Kong AN (2001) Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6: 469-477. PMID: 11595837
37. Liu X, Matsushima A, Okada H, Shimohigashi Y (2010) Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen. J Biochem 148: 247-254. doi: 10.1093/jb/mvq056 PMID: 20542892
38. Riggins RB, Mazzotta MM, Maniya OZ, Clarke R (2010) Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr Relat Cancer 17: R213-231. doi: 10.1677/ERC-10-0058 PMID: 20576803
39. Ren Y, Jiang H, Ma D, Nakaso K, Feng J (2011) Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases. Hum Mol Genet 20: 1074-1083. doi: 10.1093/hmg/ddq550 PMID: 21177257
40. Roy S, Chakravarty D, Cortez V, De Mukhopadhyay K, Bandyopadhyay A, et al. (2012) Significance of PELP1 in ER-negative breast cancer metastasis. Mol Cancer Res 10: 25-33. doi: 10.1158/1541-7786.MCR-11-0456 PMID: 22086908
41. Bursch W, Karwan A, Mayer M, Dornetshuber J, Frohwein U, et al. (2008) Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology 254: 147-157. doi: 10.1016/j.tox.2008.07.048 PMID: 18694801
42. Kohli L, Kaza N, Coric T, Byer SJ, Brossier NM, et al. (2013) 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res 73: 4395-4405. doi: 10.1158/0008-5472.CAN-12-3765 PMID: 23722551
43. Anderson E, Clarke RB, Howell A (1998) Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 3: 23-35. PMID: 10819502
44. Habashy HO, Powe DG, Rakha EA, Ball G, Macmillan RD, et al. (2010) The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast cancer research and treatment 120: 603-612. doi: 10.1007/s10549-009-0419-9 PMID: 19495959
45. Vallabhaneni S, Nair BC, Cortez V, Challa R, Chakravarty D, et al. (2010) Significance of ER-Src axis in hormonal therapy resistance. Breast cancer research and treatment.
46. Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, et al. (2011) Estrogen-related receptor gamma modulates cell proliferation and estrogen signaling in breast cancer. J Steroid Biochem Mol Biol 123: 1-7. doi: 10.1016/j.jsbmb.2010.09.002 PMID: 20883782
47. Ohshiro K, Rayala SK, El-Naggar AK, Kumar R (2008) Delivery of cytoplasmic proteins to autophagosomes. Autophagy 4: 104-106. PMID: 18000392
48. Ohshiro K, Rayala SK, Kondo S, Gaur A, Vadlamudi RK, et al. (2007) Identifying the estrogen receptor coactivator PELP1 in autophagosomes. Cancer research 67: 8164-8171. PMID: 17804729
49. Ryter SW, Cloonan SM, Choi AM (2013) Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells 36: 7-16. doi: 10.1007/s10059-013-0140-8 PMID: 23708729
50. Koritzinsky M, Wouters BG (2013) The roles of reactive oxygen species and autophagy in mediating the tolerance of tumor cells to cycling hypoxia. Semin Radiat Oncol 23: 252-261. doi: 10.1016/j.semradonc.2013.05.006 PMID: 24012339
51. Lee JH, Kim EJ, Kim DK, Lee JM, Park SB, et al. (2012) Hypoxia induces PDK4 gene expression through induction of the orphan nuclear receptor ERRgamma. PLoS One 7: e46324. doi: 10.1371/journal.pone.0046324 PMID: 23050013
52. Girard BJ, Daniel AR, Lange CA, Ostrander JH (2014) PELP1: A review of PELP1 interactions, signaling, and biology. Mol Cell Endocrinol 382: 642-651. doi: 10.1016/j.mce.2013.07.031 PMID: 23933151
53. Vadlamudi RK, Rajhans R, Chakravarty D, Nair BC, Nair SS, et al. (2010) Regulation of aromatase induction by nuclear receptor coregulator PELP1. The Journal of steroid biochemistry and molecular biology 118: 211-218. doi: 10.1016/j.jsbmb.2009.09.009 PMID: 19800002